Amundi Asset Management US’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $767M | Sell |
6,489,280
-1,167,295
| -15% | -$137M | 0.59% | 34 |
|
|
2020
Q4 | $897M | Buy |
7,656,575
+312,074
| +4% | +$34.4M | 0.76% | 22 |
|
|
2020
Q3 | $763M | Sell |
7,344,501
-280,746
| -4% | -$28.2M | 0.8% | 22 |
|
|
2020
Q2 | $699M | Buy |
7,625,247
+249,489
| +3% | +$23.9M | 0.83% | 18 |
|
|
2020
Q1 | $665M | Sell |
7,375,758
-1,592,880
| -18% | -$169M | 1.16% | 13 |
|
|
2019
Q4 | $1.02B | Buy |
8,968,638
+1,690,287
| +23% | +$185M | 1.19% | 10 |
|
|
2019
Q3 | $791M | Sell |
7,278,351
-109,389
| -1% | -$11.4M | 1.18% | 11 |
|
|
2019
Q2 | $719M | Buy |
7,387,740
+177,690
| +2% | +$16.2M | 0.59% | 49 |
|
|
2019
Q1 | $657M | Sell |
7,210,050
-518,330
| -7% | -$46.4M | 0.92% | 13 |
|
|
2018
Q4 | $703K | Sell |
7,728,380
-44,233
| -0.6% | -$4.13M | 0.65% | 15 |
|
|
2018
Q3 | $765M | Buy |
7,772,613
+2,314,278
| +42% | +$214M | 1% | 11 |
|
|
2018
Q2 | $467M | Buy |
5,458,335
+1,371,403
| +34% | +$115M | 0.67% | 24 |
|
|
2018
Q1 | $328M | Sell |
4,086,932
-1,238,000
| -23% | -$102M | 0.53% | 39 |
|
|
2017
Q4 | $430M | Buy |
5,324,932
+387,379
| +8% | +$31M | 0.66% | 27 |
|
|
2017
Q3 | $384M | Buy |
4,937,553
+46,243
| +0.9% | +$3.84M | 1.22% | 17 |
|
|
2017
Q2 | $434M | Sell |
4,891,310
-241,235
| -5% | -$20.3M | 1.42% | 13 |
|
|
2017
Q1 | $413M | Sell |
5,132,545
-120,762
| -2% | -$9.43M | 1.39% | 14 |
|
|
2016
Q4 | $374M | Buy |
5,253,307
+483,338
| +10% | +$38M | 1.32% | 18 |
|
|
2016
Q3 | $412M | Sell |
4,769,969
-205,491
| -4% | -$17.9M | 1.48% | 10 |
|
|
2016
Q2 | $432M | Buy |
4,975,460
+355,468
| +8% | +$28.7M | 1.56% | 9 |
|
|
2016
Q1 | $347M | Buy |
4,619,992
+350,421
| +8% | +$26.4M | 1.29% | 13 |
|
|
2015
Q4 | $328M | Buy |
4,269,571
+1,817,636
| +74% | +$137M | 1.23% | 14 |
|
|
2015
Q3 | $164M | Buy |
2,451,935
+75,033
| +3% | +$5.53M | 0.67% | 42 |
|
|
2015
Q2 | $176M | Sell |
2,376,902
-383,383
| -14% | -$29.3M | 0.64% | 36 |
|
|
2015
Q1 | $215M | Buy |
2,760,285
+1,971,993
| +250% | +$149M | 0.77% | 26 |
|
|
2014
Q4 | $56.9M | Sell |
788,292
-187,789
| -19% | -$13M | 0.21% | 130 |
|
|
2014
Q3 | $60.5M | Sell |
976,081
-137,009
| -12% | -$8.71M | 0.23% | 123 |
|
|
2014
Q2 | $71M | Buy |
1,113,090
+303,769
| +38% | +$18.5M | 0.27% | 110 |
|
|
2014
Q1 | $49.8M | Sell |
809,321
-68,626
| -8% | -$4M | 0.19% | 145 |
|
|
2013
Q4 | $50.4M | Buy |
877,947
+33,299
| +4% | +$1.89M | 0.19% | 142 |
|
|
2013
Q3 | $45M | Buy |
844,648
+486,889
| +136% | +$26.2M | 0.18% | 151 |
|
|
2013
Q2 | $18.4M | Buy |
+357,759
| New | +$17.7M | 0.08% | 259 |
|
Other funds holding MDT
Amundi Asset Management US's MDT Position: Q1 2021 in Review
Amundi Asset Management US reduced its Medtronic (MDT) stake by 15% in Q1 2021, selling an estimated $137M and leaving 6,489,280 shares worth $767M. The position accounts for 0.59% of the portfolio, ranked #34.
Amundi Asset Management US first reported a position in MDT in Q2 2013 and has held it in 32 quarters since. The position peaked at $1.02B in Q4 2019. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.
- Amundi Asset Management US held 6,489,280 shares of Medtronic worth $767M as of Q1 2021.
- Amundi Asset Management US sold 1,167,295 Medtronic shares in Q1 2021, an estimated $137M.
- Medtronic made up 0.59% of Amundi Asset Management US's portfolio in Q1 2021, its #34 holding.
- Amundi Asset Management US first reported a position in Medtronic in Q2 2013 and has held it in 32 quarters since.
- Amundi Asset Management US's Medtronic position peaked at $1.02B in Q4 2019.
- 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.
Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.